It's a good bet that the HQ for Baxter's biotech spinout will end up here

In Baxter International’s announcement yesterday that it’s opening a 400-employees research and development center in Cambridge, it took great pains to say that the new biopharmaceutical company it intends to spin out next year will remain headquartered in Chicago...